Stuart Millstone
Pulmonary Disease · Orange Park, FLNPI 1568481224
Payments from drug & device makers
Across 98 payments — averaging $38.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$895
- Grifols USA, LLC$614
- AstraZeneca$484
- Boehringer Ingelheim$454
- Insmed, Inc.$261
- Regeneron Healthcare Solutions, Inc.$228
- plus $804 from 14 others
What the payments were for
- Food & beverage$3,66598%
- Education$752%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 16 | $895 |
| Grifols USA, LLC | 10 | $614 |
| AstraZeneca | 11 | $484 |
| Boehringer Ingelheim | 18 | $454 |
| Insmed, Inc. | 6 | $261 |
| Regeneron Healthcare Solutions, Inc. | 6 | $228 |
| Genentech USA, Inc. | 6 | $186 |
| Novo Nordisk | 1 | $125 |
| Vapotherm Inc | 1 | $123 |
| Sunovion Pharmaceuticals Inc. | 4 | $61 |
| Mylan Specialty L.p. | 3 | $56 |
| Sanofi | 3 | $53 |
| Jazz Pharmaceuticals Inc. | 2 | $38 |
| Shire North American Group Inc | 2 | $33 |
| Circassia Inc. | 2 | $31 |
| Novartis | 2 | $31 |
| Gilead | 2 | $29 |
| Philips North America LLC | 1 | $14 |
| CSL Behring | 1 | $12 |
| Bayer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$480
- Prolastin-C Liquid$384
- XOLAIR$125
- Prolastin-C$125
- Ozempic$125
- OFEV$124
- Precision Flow$123
- Arikayce$122
- BREZTRI$121
- NUCALA$117
- DUPIXENT$101
How this compares
$3,740 in reported general payments places this provider in the 45th percentile of 953 pulmonary disease providers in Florida.
Other pulmonary disease in Orange Park
- James KrainsonMiami$11.7M
- Jose DiazLeesburg$11.2M
- Carlos MartinezHomestead$9.2M
- Leonard DunnDunedin$7.6M
- Francis AverillClearwater$6.3M
- Charles BurgerJacksonville$5.6M
- Daniel LorchBrandon$5.5M
- Lourdes BoschMiami$4.2M
- Raj KarunakaraOcala$4M
- Neal WarshoffLoxahatchee$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.